Q4 2018
Released Mar 6, 2019, before the open
10-K filed Mar 6, 2019, 65 days after period end · 0001144204-19-012434
Q4 2018 · 10-K
Revenue$0.00$0.00 — vs Q4 2017no prior Q3 2018 on file
Net Income-$3.23M-$3.23M N/M vs Q4 2017N/M vs Q3 2018
EPS Diluted-$0.15-$0.15 N/M vs Q4 2017N/M vs Q3 2018
Operating Income-$3,171,367N/M
Operating Cash Flowderived-$2,232,827N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$3.23M | -$5.33M | -$2.97M | -$4.63M |
| EPS Diluted | -$0.15 | -$0.25 | -$0.16 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR